Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Meridian Bioscience, Inc. — Predicate Candidate Screening

38 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

99 daysmedian FDA review time
210 days90th percentile
38clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K243922RevogeneMeridian Bioscience, Inc.2025-03-20900
K230901Premier HpSA Flex (619096)Meridian Bioscience, Inc.2023-07-03940
K222829Curian® Shiga ToxinMeridian Bioscience, Inc.2023-04-172100
K222779RevogeneMeridian Bioscience, Inc.2023-01-261340
K220480RevogeneMeridian Bioscience, Inc.2022-07-111430
K210976Curian CampyMeridian Bioscience, Inc.2021-12-232660
K192817Curian HpSA, Curian AnalyzerMeridian Bioscience, Inc.2020-03-131640
DEN180040Alethia CMV DNA Amplification Assay, Alethia CMV External CoMeridian Bioscience, Inc.2018-11-301230
K182559PREMIER Platinum HpSA PLUSMeridian Bioscience, Inc.2018-11-05490
K163273TRU LegionellaMeridian Bioscience, Inc.2017-02-21920
K160829illumigene Mycoplasma Direct DNA Amplification Assay, illumiMeridian Bioscience, Inc.2016-06-13800
K153661ImmunoCard STAT! HpSAMeridian Bioscience, Inc.2016-03-14840
K152285illumigene Pertussis DNA Amplification AssayMeridian Bioscience, Inc.2015-11-10900
K152800illumigene Mycoplasma DNA Amplification AssayMeridian Bioscience, Inc.2015-10-23250
K151046illumigene HSV 1&2 DNA Amplification Assay, illumigene HSV 1Meridian Bioscience, Inc.2015-07-17880
K133673ILLUMIGENE PERTUSIS DNA AMPLIFICATION ASSAY, ILLUMIGENE PERTMeridian Bioscience, Inc.2014-03-251160
K133714TRU FLUMeridian Bioscience, Inc.2014-01-03290
K123423ILLUMIGENE MYCOPLASAMA DNA AMPLIFICATION ASSAY, AND ILLUMIGEMeridian Bioscience, Inc.2013-06-052110
K122019STREPTOCOCCUS APP. SEROLOGICAL REAGENTSMeridian Bioscience, Inc.2012-09-13650
K121044ILLUMIGENE GROUP B STREPTOCOCCUS CARROT BROTH CLAIMMeridian Bioscience, Inc.2012-05-01251
K113190TRU LEGIONELLAMeridian Bioscience, Inc.2012-02-241160
K112048IMMUNOCARD C. DIFFICILE GDHMeridian Bioscience, Inc.2011-12-161510
K112125ILLUMIGENE GROUP B STREPTOCOCCUS ,EXTERNAL CONTROL KITMeridian Bioscience, Inc.2011-12-051330
K110620PREMIER C. DIFFICILE GDHMeridian Bioscience, Inc.2011-05-03610
K110012ILLUMIGENE C. DIFFICILE, AND ILLUMIPRO-10Meridian Bioscience, Inc.2011-02-24522
K100818ILLUMIGENE C. DIFFICILE, ILLUMIPRO-10 AND ILLUMIGENE C. DIFFMeridian Bioscience, Inc.2010-07-091080
K092553TRU FLU, MODEL 751230Meridian Bioscience, Inc.2009-09-11220
K090700IMMUNOCARD STAT CAMPY, MODEL 751530Meridian Bioscience, Inc.2009-05-28720
K083464PREMIER CAMPY, MODEL 618096Meridian Bioscience, Inc.2009-01-30670
K071657TRU FLUMeridian Bioscience, Inc.2007-11-151500
K071101TRU RSVMeridian Bioscience, Inc.2007-10-181820
K062546IMMUNOCARD STAT! EHEC, MODEL 751630Meridian Bioscience, Inc.2007-02-141680
K053335PREMIER PLATINUM HPSA PLUS, MODELS 601396, 601480Meridian Bioscience, Inc.2006-03-10990
K041626IMMUNOCARD STAT! FLU A & BMeridian Bioscience, Inc.2005-03-162730
K041003IMMUNOCARD TOXINS A & B, MODEL 712050Meridian Bioscience, Inc.2004-08-201231
K041445IMMUNOCARD STAT! RSV MODEL #750630Meridian Bioscience, Inc.2004-08-13730
K032222IMMUNOCARDSTAT HPSAMeridian Bioscience, Inc.2003-12-051370
K023599IMMUNOCARD STAT! E. COLI O157 PLUSMeridian Bioscience, Inc.2003-01-03670

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda